The p97-Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
04 10 2019
Historique:
received: 30 04 2019
revised: 16 09 2019
accepted: 19 09 2019
pubmed: 16 10 2019
medline: 7 1 2020
entrez: 16 10 2019
Statut: ppublish

Résumé

The E3 ubiquitin ligase RNF8 (RING finger protein 8) is a pivotal enzyme for DNA repair. However, RNF8 hyper-accumulation is tumour-promoting and positively correlates with genome instability, cancer cell invasion, metastasis and poor patient prognosis. Very little is known about the mechanisms regulating RNF8 homeostasis to preserve genome stability. Here, we identify the cellular machinery, composed of the p97/VCP ubiquitin-dependent unfoldase/segregase and the Ataxin 3 (ATX3) deubiquitinase, which together form a physical and functional complex with RNF8 to regulate its proteasome-dependent homeostasis under physiological conditions. Under genotoxic stress, when RNF8 is rapidly recruited to sites of DNA lesions, the p97-ATX3 machinery stimulates the extraction of RNF8 from chromatin to balance DNA repair pathway choice and promote cell survival after ionising radiation (IR). Inactivation of the p97-ATX3 complex affects the non-homologous end joining DNA repair pathway and hypersensitises human cancer cells to IR. We propose that the p97-ATX3 complex is the essential machinery for regulation of RNF8 homeostasis under both physiological and genotoxic conditions and that targeting ATX3 may be a promising strategy to radio-sensitise BRCA-deficient cancers.

Identifiants

pubmed: 31613024
doi: 10.15252/embj.2019102361
pmc: PMC6826192
doi:

Substances chimiques

Chromatin 0
DNA-Binding Proteins 0
Nuclear Proteins 0
RNF8 protein, human 0
Ubiquitin 0
Ubiquitin-Protein Ligases EC 2.3.2.27
Ataxin-3 EC 3.4.19.12
Proteasome Endopeptidase Complex EC 3.4.25.1
Adenosine Triphosphatases EC 3.6.1.-
p97 ATPase EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e102361

Subventions

Organisme : Cancer Research UK (CRUK)
ID : C5255/A15935
Pays : International
Organisme : Spanish Ministry of Science and Universities
ID : SAF2016-80626-R
Pays : International
Organisme : Medical Research Council
ID : MR/M000354/1
Pays : United Kingdom
Organisme : Swiss National Science Foundation
ID : 31003A_141197
Pays : Switzerland
Organisme : Kraeftens Bekaempelse (Danish Cancer Society)
ID : R146-RP11394
Pays : International
Organisme : UK Research and Innovation | Medical Research Council (MRC)
ID : MC_EX_MR/K022830/1
Pays : International
Organisme : Medical Research Council
ID : MC_UU_00001/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_MR/K022830/1
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Published under the terms of the CC BY 4.0 license.

Références

Nat Rev Mol Cell Biol. 2013 Oct;14(10):661-72
pubmed: 24002223
PLoS Genet. 2008 Jun 27;4(6):e1000110
pubmed: 18584027
Nat Struct Mol Biol. 2011 Nov 27;18(12):1345-50
pubmed: 22120668
F1000Res. 2017 Aug 3;6:1318
pubmed: 28815021
Nat Commun. 2014 Apr 28;5:3695
pubmed: 24770583
Mol Cell. 2018 Oct 18;72(2):250-262.e6
pubmed: 30270107
J Cell Biol. 2016 Feb 15;212(4):465-80
pubmed: 26880203
Cell. 2017 May 4;169(4):722-735.e9
pubmed: 28475898
Nat Cell Biol. 2011 Aug 07;13(9):1116-23
pubmed: 21822278
Mol Cell. 2016 Nov 17;64(4):704-719
pubmed: 27871366
J Biol Chem. 2016 Apr 29;291(18):9396-410
pubmed: 26903517
Mol Cell. 2016 Oct 6;64(1):51-64
pubmed: 27546791
Radiother Oncol. 2011 Oct;101(1):7-12
pubmed: 21737170
Nat Struct Mol Biol. 2013 Dec;20(12):1425-33
pubmed: 24240613
Nat Rev Cancer. 2016 Jan;16(1):35-42
pubmed: 26667849
Front Genet. 2013 Apr 30;4:60
pubmed: 23641252
Cancer Res. 2005 Sep 1;65(17):7533-40
pubmed: 16140914
Nat Cell Biol. 2011 Oct 23;13(11):1376-82
pubmed: 22020440
Science. 2007 May 25;316(5828):1198-202
pubmed: 17525341
Nat Struct Mol Biol. 2016 Nov;23(11):995-1002
pubmed: 27669035
BMC Mol Biol. 2009 Jun 05;10:55
pubmed: 19500350
EMBO J. 2012 May 30;31(11):2511-27
pubmed: 22531782
Mol Cell. 2017 May 18;66(4):458-472.e5
pubmed: 28525740
Nucleic Acids Res. 2012 Jan;40(1):196-205
pubmed: 21911360
Mol Biol Cell. 2016 Dec 1;27(24):3791-3799
pubmed: 27733626
Nature. 2015 Nov 19;527(7578):389-93
pubmed: 26503038
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16910-5
pubmed: 17940005
Nat Cell Biol. 2012 Feb 02;14(2):117-23
pubmed: 22298039
FEBS Lett. 2015 Sep 14;589(19 Pt A):2578-89
pubmed: 26320413
Mol Cell. 2012 Aug 24;47(4):497-510
pubmed: 22920291
EMBO J. 2017 Apr 13;36(8):1066-1083
pubmed: 28275011
Hum Mol Genet. 2006 Aug 15;15(16):2409-20
pubmed: 16822850
J Biol Chem. 2016 Jan 22;291(4):1789-802
pubmed: 26559976
Nat Rev Mol Cell Biol. 2017 Aug;18(8):495-506
pubmed: 28512351
J Biol Chem. 2011 Jun 24;286(25):22355-61
pubmed: 21558560
Mol Cell. 2019 Mar 21;73(6):1267-1281.e7
pubmed: 30704900
Mol Cell Oncol. 2016 Oct 13;3(6):e1242454
pubmed: 28090581
Mol Cell Biol. 2003 Sep;23(18):6469-83
pubmed: 12944474
J Cell Biol. 2006 Apr 10;173(1):19-26
pubmed: 16606690
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4834-9
pubmed: 21383145
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
Cell Cycle. 2015;14(9):1413-25
pubmed: 25894431
Cell. 2012 Sep 14;150(6):1182-95
pubmed: 22980979
J Cell Sci. 2014 Sep 15;127(Pt 18):3877-83
pubmed: 25146396
Cell. 2012 Aug 17;150(4):697-709
pubmed: 22884692
Science. 2007 Dec 7;318(5856):1637-40
pubmed: 18006705
Cell Rep. 2015 Jan 13;10(2):226-38
pubmed: 25578731
Mol Cell. 2016 Sep 15;63(6):1021-33
pubmed: 27618486
J Exp Clin Cancer Res. 2016 Jun 04;35(1):88
pubmed: 27259701
Oncotarget. 2017 May 2;8(18):29963-29975
pubmed: 28415784
Cell. 2007 Nov 30;131(5):887-900
pubmed: 18001824
J Biol Chem. 2008 Sep 26;283(39):26436-43
pubmed: 18599482
Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):776-784
pubmed: 29413288
Science. 2007 May 25;316(5828):1202-5
pubmed: 17525342
J Med Chem. 2015 Dec 24;58(24):9480-97
pubmed: 26565666
J Cell Biol. 2006 Sep 25;174(7):963-71
pubmed: 17000876
J Mol Biol. 2014 Jul 29;426(15):2886-99
pubmed: 24878061
Nat Struct Mol Biol. 2012 Jan 22;19(2):201-6
pubmed: 22266820
Cancer Res. 2012 Oct 1;72(19):4974-83
pubmed: 22865450
J Biol Chem. 2017 Nov 10;292(45):18392-18407
pubmed: 28939772
Cell Cycle. 2012 Mar 15;11(6):1062-9
pubmed: 22391235
Mol Cell Biol. 2000 Nov;20(22):8602-12
pubmed: 11046155
Nat Cell Biol. 2016 Dec 23;19(1):1-9
pubmed: 28008184
Mol Cell. 2016 Oct 6;64(1):189-198
pubmed: 27716483
Nat Cell Biol. 2018 Aug;20(8):954-965
pubmed: 30022119
Cell. 2009 Feb 6;136(3):435-46
pubmed: 19203579
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20759-63
pubmed: 18077395
Mol Cell. 2018 Feb 1;69(3):505-516.e5
pubmed: 29395066
Mol Cell. 2018 Mar 1;69(5):866-878.e7
pubmed: 29499138
J Cell Biol. 2003 Jul 7;162(1):71-84
pubmed: 12847084
Nature. 2018 Aug;560(7716):117-121
pubmed: 30022168
DNA Repair (Amst). 2006 Aug 13;5(8):986-96
pubmed: 16955546
Hum Mol Genet. 2003 Dec 1;12(23):3195-205
pubmed: 14559776
Nat Cell Biol. 2013 May;15(5):526-32
pubmed: 23624404
Nat Chem Biol. 2013 Sep;9(9):548-56
pubmed: 23892893
J Biol Chem. 2013 Feb 1;288(5):2941-50
pubmed: 23233665
Mol Cell. 2016 Feb 4;61(3):449-460
pubmed: 26748828
Cell. 2009 Feb 6;136(3):420-34
pubmed: 19203578
PLoS One. 2012;7(9):e43563
pubmed: 22970133
EMBO J. 2012 Apr 18;31(8):1865-78
pubmed: 22373579
DNA Repair (Amst). 2014 Jul;19:169-75
pubmed: 24746645
Exp Cell Res. 2014 Nov 15;329(1):9-17
pubmed: 25169698
Biochem J. 2015 Oct 1;471(1):1-11
pubmed: 26392571
J Biol Chem. 2012 Nov 23;287(48):40618-28
pubmed: 23055523
J Struct Biol. 2012 Aug;179(2):78-82
pubmed: 22450227
Cell. 2017 May 18;169(5):792-806
pubmed: 28525752

Auteurs

Abhay Narayan Singh (AN)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Judith Oehler (J)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Ignacio Torrecilla (I)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Susan Kilgas (S)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Shudong Li (S)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Bruno Vaz (B)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Claire Guérillon (C)

Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

John Fielden (J)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Esperanza Hernandez-Carralero (E)

Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.
Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.

Elisa Cabrera (E)

Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.
Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.

Iain Dc Tullis (ID)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Mayura Meerang (M)

Institute of Pharmacology and Toxicology-Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.

Paul R Barber (PR)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Raimundo Freire (R)

Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.
Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.
Universidad Fernando Pessoa Canarias, Santa Maria de Guia, Spain.

Jason Parsons (J)

Department of Molecular and Clinical Cancer Medicine, Cancer Research Centre, University of Liverpool, Liverpool, UK.

Borivoj Vojnovic (B)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Anne E Kiltie (AE)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Niels Mailand (N)

Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Kristijan Ramadan (K)

Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH